• Explore /
  • Poster
  • / Nivolumab + ipilimumab combination in patients with DNA mismatch repair-deficient/microsatellite instability-high (dMMR/MSI-H) metastatic colorectal cancer (mCRC): First report of the full cohort from CheckMate-142.

Nivolumab + ipilimumab combination in patients with DNA mismatch repair-deficient/microsatellite instability-high (dMMR/MSI-H) metastatic colorectal cancer (mCRC): First report of the full cohort from CheckMate-142.

Abstract Poster

Authors

Thierry Andre

Thierry Andre

Saint-Antoine Hospital, Paris, France

Thierry Andre , Sara Lonardi , Mark Wong , Heinz-Josef Lenz , Fabio Gelsomino , Massimo Aglietta , Michael Morse , Eric Van Cutsem , Raymond S. McDermott , Andrew G Hill , Michael B. Sawyer , Alain Hendlisz , Bart Neyns , Magali Svrcek , Rebecca Anne Moss , Jean-Marie Ledeine , Z. Alexander Cao , Shital Kamble , Scott Kopetz , Michael J. Overman

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT02060188

Citation

J Clin Oncol 36, 2018 (suppl 4S; abstr 553)

DOI

10.1200/JCO.2018.36.4_suppl.553

Abstract #

553

Poster Bd #

A2

Abstract Disclosures

Similar Posters

First Author: Heinz-Josef Lenz

First Author: Michael J. Overman

First Author: Thierry Andre

First Author: Michael J. Overman